{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:20Z","timestamp":1790845940737,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["ST.A.230.17.017"],"award-info":[{"award-number":["ST.A.230.17.017"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["ST.A040.16.022"],"award-info":[{"award-number":["ST.A040.16.022"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.advms.2020.03.004","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T18:27:04Z","timestamp":1588098424000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children"],"prefix":"10.1016","volume":"65","author":[{"given":"Barbara","family":"Iwa\u0144czak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Ruczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Matusiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Pytrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Matusiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Krzesiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2020.03.004_bib1","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2020.03.004_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","article-title":"Definition of phenotypic characteristics of childhood \u2013 onset inflammatory bowel disease","volume":"135","author":"Van Limbergen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2020.03.004_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.advms.2020.03.004_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ibd.23013","article-title":"EUROKIDS Porto IBD Working Group of ESPGHAN. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry","volume":"19","author":"Levine","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ibd.21383","article-title":"Acute severe ulcerative colitis in children: a systematic review","volume":"17","author":"Turner","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.sempedsurg.2017.10.006","article-title":"Management of acute severe ulcerative colitis in children","volume":"26","author":"Siow","year":"2017","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.advms.2020.03.004_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.advms.2020.03.004_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.gtc.2012.01.002","article-title":"Genetics in a diagnosing and managing inflammatory bowel disease","volume":"41","author":"McCauley","year":"2012","journal-title":"Gastroenterol Clin NA"},{"key":"10.1016\/j.advms.2020.03.004_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ajg.2010.481","article-title":"Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN and the Porto IBD Working Group of ESPGHAN","volume":"106","author":"Turner","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.advms.2020.03.004_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development and evaluation of a pediatric ulcerative colitis activity index (PUCAI): a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2020.03.004_bib12","first-page":"2467","article-title":"Biomarkers of inflammatory bowel disease: from classical laboratory tools to personalized medicine","volume":"21","author":"Viennois","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.advms.2020.03.004_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPG.0b013e3182662233","article-title":"Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines","volume":"55","author":"Turner","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.03.004_bib14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.03.004_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acide) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.advms.2020.03.004_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2020.03.004_bib17","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.3748\/wjg.v23.i30.5469","article-title":"Treating children with inflammatory bowel disease: current and new prospectives","volume":"23","author":"Guariso","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.advms.2020.03.004_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/00365520410007971","article-title":"Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease","volume":"39","author":"R\u00f8seth","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.advms.2020.03.004_bib19","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.3748\/wjg.v21.i40.11469","article-title":"Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?","volume":"21","author":"Boon","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.advms.2020.03.004_bib20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s10620-010-1494-9","article-title":"Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease","volume":"56","author":"Manolakis","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.advms.2020.03.004_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ajg.2012.33","article-title":"The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease","volume":"107","author":"Henderson","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.advms.2020.03.004_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MPG.0b013e31816533d3","article-title":"Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease","volume":"48","author":"Joishy","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.03.004_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.17219\/acem\/26003","article-title":"Fecal calprotectin as an activity marker of inflammatory bowel disease in children","volume":"24","author":"Krzesiek","year":"2015","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.advms.2020.03.004_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ibd.20376","article-title":"Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease","volume":"14","author":"Walkiewicz","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.MPG.0000154657.08994.94","article-title":"Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms","volume":"40","author":"Fagerberg","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.03.004_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.advms.2018.08.001","article-title":"The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease","volume":"64","author":"Daniluk","year":"2019","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.advms.2020.03.004_bib27","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s10620-011-1633-y","article-title":"Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease","volume":"56","author":"Aomatsu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.advms.2020.03.004_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.dld.2008.01.017","article-title":"Fecal calprotectin as reliable non-invasive marker to asses severity of mucosal inflammation in children with inflammatory bowel disease","volume":"40","author":"Canani","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib29","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1097\/MPG.0b013e31810e75a9","article-title":"Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease","volume":"45","author":"Fagerberg","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.03.004_bib30","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D'Haens","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MIB.0000000000001082","article-title":"Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide","volume":"23","author":"Heida","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2020.03.004_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MPG.0000000000000939","article-title":"Avoid endoscopy in children with suspected inflammatory bowel disease who have normal calprotectin levels","volume":"62","author":"Heida","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2020.03.004_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPG.0000000000000615","article-title":"Faecal calprotectin in suspected paediatric inflammatory bowel disease","volume":"60","author":"Degraeuwe","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.advms.2020.03.004_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.17219\/acem\/37031","article-title":"Metalloproteinase \u2013 3 and \u2013 9 as novel markers in the evaluation of ulcerative colitis activity in children","volume":"23","author":"Kofla\u2013D\u0142ubacz","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.advms.2020.03.004_bib35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.gastrohep.2016.01.015","article-title":"Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease","volume":"39","author":"Miranda-Garc\u00eda","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2020.03.004_bib36","first-page":"802","article-title":"\u2013C-Reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activityin symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Mm J Gastroenterol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112618302529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112618302529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:40:43Z","timestamp":1761824443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112618302529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1896112618302529"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2020.03.004","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2020.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}